SHL Medical opens new US$220 million manufacturing facility in the US to serve growing autoinjector market

ZUG,Switzerland,April 1, 2025/PRNewswire/ -- SHL Medical, a global leader in the design, development, and manufacturing of advanced self-injection solutions, has officially inaugurated its new state-of-the-art manufacturing facility inNorth Charleston, South Carolina. This strategic expansion marks a significant milestone in the Swiss-based company's global growth, reinforcing its commitment to meeting the increasing worldwide demand for autoinjectors, most notably used in the cardiometabolic sector.

The new facility will manufacture SHL Medical's industry-leading autoinjectors, which are used in some of the world's best-selling medications in areas such as endocrine and metabolic disorders (including GLP-1 therapies), dermatology, musculoskeletal diseases, and other therapy areas. It ensures a reliable supply of these critical devices to millions of patients worldwide.  

Strengthening production capacity and US market presence

SHL Medical is significantly increasing its production capacity to meet growing demand inNorth Americawhile strengthening supply chain resilience."US-based production is a major step forward in our global expansion and reinforces our position as the leader in providing end-to-end drug delivery solutions,"saidUlrich Faessler, CEO& Chairman of SHL Medical."With our established site inTaiwanand the upcoming facility inSwitzerland, we will be the only autoinjector manufacturer operating across three continents, bringing us even closer to our customers."

The fully automatized 360,000 ft²facility represents aUS$220 millioninvestment and has already created over 300 local jobs, contributing to the economic growth of the region. Equipped with cutting-edge medical device injection molding technology and fully automated assembly capabilities, the site ensures unmatched precision, efficiency, and quality in SHL Medical's advanced drug delivery solutions.

By leveraging its existing final assembly, labeling, and packaging operations inDeerfield Beach, Florida, and integrating recent acquisitions under SHL Advantec, theNorth Charlestonfacility enhances SHL Medical's US presence and solidifies its leadership in large-scale autoinjector production. The company is on track to deliver 1.5 billion devices to customers in 2025.

"The most trusted autoinjector brand is now made in theUSA. We are proud to be contributing to the growth of the local economy and becoming a key player in the area while contributing to our sustainability goals."addsKimberlee Steele, Managing Director North America at SHL Medical.

The Grand Opening event, attended by approximately 180 guests, includingSouth Carolina'sGovernorHenry McMasterand Swiss Embassy Consul GeneralUrs Broennimann, marked the official opening of SHL Medical's innovative autoinjector production inthe United States.

For more detailed information about SHL's latest expansion strategy, please refer to the press releases below:

New manufacturing site in Zug,Switzerland

New manufacturing site inNorth Charleston, NC, USA

SHL Medical announces plans to establish SHL Advantec

SHL Medical acquires Swiss toolmaking company SMC Mould Innovation

SHL Medical further strengthens vertical capabilities with the acquisition of US manufacturer Superior Tooling Inc.

SHL Medical acquires 100% of the shares in Swiss company LCA Automation

About SHL Medical

SHL Medical is a pioneering leader in self-injection solutions, such as autoinjectors. Driven by our core purpose of"enabling patients'independence", we partner with leading pharma and biotech companies to develop self-injection systems and digital solutions enhance patients'treatment experience and quality of life. With over 5,000 employees located across our offices inSwitzerland,USA,Sweden, andTaiwan, we rely on our comprehensive in-house manufacturing capabilities to provide end-to-end services, from design, development, to final assembly, labeling, and packaging. For additional information, visitwww.shl-medical.com

Global Media Contact

Burson Switzerland

shl-pressoffice@bcw-global.com

SOURCE SHL Medical